These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 21040217

  • 41. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH, Wu L, Raymon HK, Chen RS, Corral L, Shirley MA, Narla RK, Gamez J, Muller GW, Stirling DI, Bartlett JB, Schafer PH, Payvandi F.
    Cancer Res; 2006 Jan 15; 66(2):951-9. PubMed ID: 16424030
    [Abstract] [Full Text] [Related]

  • 42. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L, Wu Y, Lin L, Wang J, Wu Y, Chen Y, Yi Z, Liu M, Pang X.
    Cancer Sci; 2011 Jan 15; 102(1):219-25. PubMed ID: 21087351
    [Abstract] [Full Text] [Related]

  • 43. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 44. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK, Han EK, Credo B, Jae HS, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng SC.
    Cancer Res; 2001 Jul 15; 61(14):5480-5. PubMed ID: 11454695
    [Abstract] [Full Text] [Related]

  • 45. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
    Wang LL, Li JJ, Zheng ZB, Liu HY, Du GJ, Li S.
    Eur J Pharmacol; 2004 Oct 11; 502(1-2):1-10. PubMed ID: 15464084
    [Abstract] [Full Text] [Related]

  • 46. YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance.
    Zhao H, Quan H, Xie C, Xu Y, Xie F, Hu Y, Lou L.
    Cancer Lett; 2012 Jan 01; 314(1):54-62. PubMed ID: 21982683
    [Abstract] [Full Text] [Related]

  • 47. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
    Zhao DG, Chen J, Du YR, Ma YY, Chen YX, Gao K, Hu BR.
    J Med Chem; 2013 Feb 28; 56(4):1467-77. PubMed ID: 23360369
    [Abstract] [Full Text] [Related]

  • 48. Syringic acid from Tamarix aucheriana possesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells.
    Abaza MS, Al-Attiyah R, Bhardwaj R, Abbadi G, Koyippally M, Afzal M.
    Pharm Biol; 2013 Sep 28; 51(9):1110-24. PubMed ID: 23745612
    [Abstract] [Full Text] [Related]

  • 49. Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents.
    Li WT, Hwang DR, Song JS, Chen CP, Chen TW, Lin CH, Chuu JJ, Lien TW, Hsu TA, Huang CL, Tseng HY, Lin CC, Lin HL, Chang CM, Chao YS, Chen CT.
    Invest New Drugs; 2012 Feb 28; 30(1):164-75. PubMed ID: 20890633
    [Abstract] [Full Text] [Related]

  • 50. A new chiral 2-(ethylthio)-thiazolone analogue shows strong antitumor activities by inducing cancer cell apoptosis and inhibiting angiogenesis.
    Song H, Kai M, Liu X, Yin W, Zeng Q, Yao X, Wang R.
    Anticancer Drugs; 2012 Oct 28; 23(9):914-22. PubMed ID: 22614105
    [Abstract] [Full Text] [Related]

  • 51. I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicity.
    Ahn S, Duke CB, Barrett CM, Hwang DJ, Li CM, Miller DD, Dalton JT.
    Mol Cancer Ther; 2010 Nov 28; 9(11):2859-68. PubMed ID: 20829196
    [Abstract] [Full Text] [Related]

  • 52. Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
    Li CM, Lu Y, Chen J, Costello TA, Narayanan R, Dalton MN, Snyder LM, Ahn S, Li W, Miller DD, Dalton JT.
    Pharm Res; 2012 Nov 28; 29(11):3053-63. PubMed ID: 22760659
    [Abstract] [Full Text] [Related]

  • 53. PD806: a novel oral vascular disrupting agent shows antitumor and antivascular effects in vitro and in vivo.
    Yao N, Gao M, Ren K, Jiang X, Li Y, Jiang C, Huang D, Liu W, Wang X, Fang Z, Sun Z, Zhang J, Ni Y.
    Anticancer Drugs; 2015 Feb 28; 26(2):148-59. PubMed ID: 25222529
    [Abstract] [Full Text] [Related]

  • 54. A novel anti-microtubule agent with carbazole and benzohydrazide structures suppresses tumor cell growth in vivo.
    Ohira M, Iwasaki Y, Tanaka C, Kuroki M, Matsuo N, Kitamura T, Yukuhiro M, Morimoto H, Pang N, Liu B, Kiyono T, Amemiya M, Tanaka K, Yoshida K, Sugimoto N, Ohshima T, Fujita M.
    Biochim Biophys Acta; 2015 Sep 28; 1850(9):1676-84. PubMed ID: 25960391
    [Abstract] [Full Text] [Related]

  • 55. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
    Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C.
    Mol Cancer Ther; 2006 Feb 28; 5(2):450-6. PubMed ID: 16505120
    [Abstract] [Full Text] [Related]

  • 56. Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent.
    Li Q, Woods KW, Claiborne A, Gwaltney SL, Barr KJ, Liu G, Gehrke L, Credo RB, Hui YH, Lee J, Warner RB, Kovar P, Nukkala MA, Zielinski NA, Tahir SK, Fitzgerald M, Kim KH, Marsh K, Frost D, Ng SC, Rosenberg S, Sham HL.
    Bioorg Med Chem Lett; 2002 Feb 11; 12(3):465-9. PubMed ID: 11814821
    [Abstract] [Full Text] [Related]

  • 57. N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility.
    Aceves-Luquero C, Galiana-Roselló C, Ramis G, Villalonga-Planells R, García-España E, Fernández de Mattos S, Peláez R, Llinares JM, González-Rosende ME, Villalonga P.
    Biochem Pharmacol; 2016 Sep 01; 115():28-42. PubMed ID: 27349984
    [Abstract] [Full Text] [Related]

  • 58. Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation.
    Lee HY, Chang JY, Chang LY, Lai WY, Lai MJ, Shih KH, Kuo CC, Chang CY, Liou JP.
    Org Biomol Chem; 2011 May 07; 9(9):3154-7. PubMed ID: 21416070
    [Abstract] [Full Text] [Related]

  • 59. Cytotoxic and antivascular 1-methyl-4-(3-fluoro-4-methoxyphenyl)-5-(halophenyl)-imidazoles.
    Biersack B, Muthukumar Y, Schobert R, Sasse F.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6270-3. PubMed ID: 21963303
    [Abstract] [Full Text] [Related]

  • 60. Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor.
    Li CM, Wang Z, Lu Y, Ahn S, Narayanan R, Kearbey JD, Parke DN, Li W, Miller DD, Dalton JT.
    Cancer Res; 2011 Jan 01; 71(1):216-24. PubMed ID: 21084278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.